Literature DB >> 30323273

Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Michele Carbone1, Ivano Amelio2, El Bachir Affar3, James Brugarolas4, Lisa A Cannon-Albright5,6, Lewis C Cantley7, Webster K Cavenee8, Zhijian Chen9, Carlo M Croce10, Alan D' Andrea11, David Gandara12, Carlotta Giorgi13, Wei Jia14, Qing Lan15, Tak Wah Mak16, James L Manley17, Katsuhiko Mikoshiba18, Jose N Onuchic19, Harvey I Pass20, Paolo Pinton13, Carol Prives21, Nathaniel Rothman15, Said M Sebti22, James Turkson14, Xifeng Wu23, Haining Yang14, Herbert Yu14, Gerry Melino24,25.   

Abstract

The relative contribution of intrinsic genetic factors and extrinsic environmental ones to cancer aetiology and natural history is a lengthy and debated issue. Gene-environment interactions (G x E) arise when the combined presence of both a germline genetic variant and a known environmental factor modulates the risk of disease more than either one alone. A panel of experts discussed our current understanding of cancer aetiology, known examples of G × E interactions in cancer, and the expanded concept of G × E interactions to include somatic cancer mutations and iatrogenic environmental factors such as anti-cancer treatment. Specific genetic polymorphisms and genetic mutations increase susceptibility to certain carcinogens and may be targeted in the near future for prevention and treatment of cancer patients with novel molecularly based therapies. There was general consensus that a better understanding of the complexity and numerosity of G × E interactions, supported by adequate technological, epidemiological, modelling and statistical resources, will further promote our understanding of cancer and lead to novel preventive and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30323273      PMCID: PMC6219489          DOI: 10.1038/s41418-018-0213-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  215 in total

1.  A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility.

Authors:  Ruyang Zhang; Minjie Chu; Yang Zhao; Chen Wu; Huan Guo; Yongyong Shi; Juncheng Dai; Yongyue Wei; Guangfu Jin; Hongxia Ma; Jing Dong; Honggang Yi; Jianling Bai; Jianhang Gong; Chongqi Sun; Meng Zhu; Tangchun Wu; Zhibin Hu; Dongxin Lin; Hongbing Shen; Feng Chen
Journal:  Carcinogenesis       Date:  2014-03-22       Impact factor: 4.944

2.  The p53 family members have distinct roles during mammalian embryonic development.

Authors:  Jeanine L Van Nostrand; Margot E Bowen; Hannes Vogel; Maria Barna; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-02-17       Impact factor: 15.828

Review 3.  Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signaling.

Authors:  Tamara Vervloessem; Martijn Kerkhofs; Rita M La Rovere; Flore Sneyers; Jan B Parys; Geert Bultynck
Journal:  Cell Calcium       Date:  2017-06-04       Impact factor: 6.817

4.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

5.  Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

Authors:  Andrew W Roberts; Matthew S Davids; John M Pagel; Brad S Kahl; Soham D Puvvada; John F Gerecitano; Thomas J Kipps; Mary Ann Anderson; Jennifer R Brown; Lori Gressick; Shekman Wong; Martin Dunbar; Ming Zhu; Monali B Desai; Elisa Cerri; Sari Heitner Enschede; Rod A Humerickhouse; William G Wierda; John F Seymour
Journal:  N Engl J Med       Date:  2015-12-06       Impact factor: 91.245

6.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

7.  Creation of a national resource with linked genealogy and phenotypic data: the Veterans Genealogy Project.

Authors:  Lisa A Cannon-Albright; Sue Dintelman; Tim Maness; Steve Backus; Alun Thomas; Laurence J Meyer
Journal:  Genet Med       Date:  2013-01-17       Impact factor: 8.822

8.  Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.

Authors:  Rosalyn D Ferguson; Ruslan Novosyadlyy; Yvonne Fierz; Nyosha Alikhani; Hui Sun; Shoshana Yakar; Derek Leroith
Journal:  Breast Cancer Res       Date:  2012-01-07       Impact factor: 6.466

9.  Germline BAP1 mutations induce a Warburg effect.

Authors:  Angela Bononi; Haining Yang; Carlotta Giorgi; Simone Patergnani; Laura Pellegrini; Mingming Su; Guoxiang Xie; Valentina Signorato; Sandra Pastorino; Paul Morris; Greg Sakamoto; Shafi Kuchay; Giovanni Gaudino; Harvey I Pass; Andrea Napolitano; Paolo Pinton; Wei Jia; Michele Carbone
Journal:  Cell Death Differ       Date:  2017-06-30       Impact factor: 15.828

10.  Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense.

Authors:  Angelo D'Alessandro; Ivano Amelio; Celia R Berkers; Alexey Antonov; Karen H Vousden; Gerry Melino; Lello Zolla
Journal:  Oncotarget       Date:  2014-09-15
View more
  13 in total

Review 1.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

2.  BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.

Authors:  Flavia Novelli; Angela Bononi; Qian Wang; Fang Bai; Simone Patergnani; Franz Kricek; Ellinor Haglund; Joelle S Suarez; Mika Tanji; Ronghui Xu; Yasutaka Takanishi; Michael Minaai; Sandra Pastorino; Paul Morris; Greg Sakamoto; Harvey I Pass; Haithem Barbour; Giovanni Gaudino; Carlotta Giorgi; Paolo Pinton; Jose N Onuchic; Haining Yang; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

Review 3.  Opportunities for Gene and Environment Research in Cancer: An Updated Review of NCI's Extramural Grant Portfolio.

Authors:  Armen A Ghazarian; Naoko Ishibe Simonds; Gabriel Y Lai; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-15       Impact factor: 4.090

4.  Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.

Authors:  Huamei Tang; Lijuan Kan; Tong Ou; Dayang Chen; Xiaowen Dou; Wei Wu; Xiang Ji; Mengmeng Wang; Zengyan Zong; Hongmei Mo; Xiuming Zhang; Dan Xiong
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 5.  Lessons from the Endoplasmic Reticulum Ca2+ Transporters-A Cancer Connection.

Authors:  Xingjian Zhai; Andra Mihaela Sterea; Yassine El Hiani
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

Review 6.  Clinical update on head and neck cancer: molecular biology and ongoing challenges.

Authors:  Elham Alsahafi; Katheryn Begg; Ivano Amelio; Nina Raulf; Philippe Lucarelli; Thomas Sauter; Mahvash Tavassoli
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

7.  The biochemistry of cell death : Cell Death: Apoptosis and Other Means to an End, Second Edition by Douglas R. Green, St. Jude Children's Research Hospital, Cold Spring Harbor Laboratory Press, New York, 2018.

Authors:  Carlotta Zampieri; Carlo Ganini; Gerry Melino
Journal:  Cell Death Dis       Date:  2020-04-20       Impact factor: 8.469

8.  P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.

Authors:  Caterina Costa; Paola Indovina; Eliseo Mattioli; Iris Maria Forte; Carmelina Antonella Iannuzzi; Luca Luzzi; Cristiana Bellan; Simona De Summa; Enrico Bucci; Domenico Di Marzo; Marisa De Feo; Luciano Mutti; Francesca Pentimalli; Antonio Giordano
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

9.  BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.

Authors:  Alice Guazzelli; Parisa Meysami; Emyr Bakker; Constantinos Demonacos; Antonio Giordano; Marija Krstic-Demonacos; Luciano Mutti
Journal:  Int J Mol Sci       Date:  2019-01-19       Impact factor: 5.923

Review 10.  How asbestos and other fibers cause mesothelioma.

Authors:  Giovanni Gaudino; Jiaming Xue; Haining Yang
Journal:  Transl Lung Cancer Res       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.